Heartwood Wealth Advisors LLC Bristol Myers Squibb CO Transaction History

Heartwood Wealth Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $1,656 - $1,839	-26 Reduced 0.79%	3,277 $209,000
Q4 2022 Jan 12, 2023	SELL	$68.48 - $81.09 $4,725 - $5,595	-69 Reduced 2.05%	3,303 $0
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $98 - $58,091	756 Added 28.9%	3,372 $240,000
Q2 2022 Jul 25, 2022	BUY	$72.62 - $79.98 $189,973 - $209,227	2,616 New	2,616 $201,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Heartwood Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Heartwood Wealth Advisors LLC with notifications on news.